Chlorhexidine gluconate is a bisguanide germicide currently available with 70% isopropanol (Hibistat, Hibitane) or a detergent (Hibiclens, Hibiscrub) for preoperative skin preparation. As these solvents are toxic to the cornea, we investigated the safety and efficacy of aqueous chlorhexidine solutions for ophthalmic use. Chlorhexidine in Tris-glycine buffer was evaluated for retardation of epithelial regeneration after experimental corneal abrasion in rabbits. Irrigant concentrations of 2.0 and 4.0% chlorhexidine significantly slowed the healing rate (0.546 and 0.076 mm/h, respectively) compared with saline controls (0.938 mm/h). Irrigant concentrations of .l% did not statistically delay healing (P > 0.4). In a separate group of animals, the right conjunctivae of pigmented rabbits were inoculated with Staphylococcus epidermidis (_107 organisms per eye) and irrigated with 40 ,lI of aqueous chlorhexidine in concentrations of 0.1, 0.5, and 1.0%; the left eyes were irrigated with saline or left untreated. Quantitative conjunctival cultures were obtained, and the total number of organisms recovered per eye was calculated. All chlorhexidine-treated eyes showed significant reduction in organisms compared with either untreated or saline-irrigated control eyes (P < 0.001). In vitro antimicrobial susceptibility testing demonstrated chlorhexidine in concentrations of 0.1 to 4% to be highly active against a variety of gram-positive and gram-negative bacterial pathogens by disk diffusion and broth diffusion assays.
conjunctivae of pigmented rabbits were inoculated with Staphylococcus epidermidis (_107 organisms per eye) and irrigated with 40 ,lI of aqueous chlorhexidine in concentrations of 0.1, 0.5, and 1.0%; the left eyes were irrigated with saline or left untreated. Quantitative conjunctival cultures were obtained, and the total number of organisms recovered per eye was calculated. All chlorhexidine-treated eyes showed significant reduction in organisms compared with either untreated or saline-irrigated control eyes (P < 0.001). In vitro antimicrobial susceptibility testing demonstrated chlorhexidine in concentrations of 0.1 to 4% to be highly active against a variety of gram-positive and gram-negative bacterial pathogens by disk diffusion and broth diffusion assays. Topical aqueous chlorhexidine may be an alternate agent for preoperative conjunctival antisepsis.
Postoperative infection is a most serious complication after ophthalmic surgery. Although the sources of contamination are multiple, the microbial population of the ocular surface is an important reservoir (8) . Several different antiseptic agents are used for preoperative skin preparation in ocular surgery (1) , but postoperative infection may be related more commonly to residual microflora from the conjunctiva rather than from the periocular skin (8) .
Topical antibiotics have been suggested to reduce the conjunctival bacterial population (7, 19) , but there is no consensus regarding the optimal regimen. Unfortunately, most antiseptic agents such as povidone-iodine and hexachlorophene are toxic to the corneal epithelium (3, 14) . Chlorhexidine, however, has excellent germicidal properties (12, 13, (16) (17) (18) 21) with persistent effect (16, 17, 21) and has been successfully used in contact lens solutions. Toxicological studies have shown that chlorhexidine is safe as a contact lens disinfectant (2, 10) , and direct topical application of concentrations of up to 2% causes neither visible nor light microscopic corneal changes (9, 15) , although superficial epithelial changes are noted by electron microscopy (4, 6) . We have investigated the efficacy of various concentrations of aqueous chlorhexidine gluconate in experimental models to study its use as a potential preoperative antiseptic agent for the eye.
MATERIALS AND METHODS
Toxicity studies. The method of assessing the corneal epithelial toxicity was similar to that described by Ubels et al. (20) . Pigmented rabbits weighing 2 to 3 kg were anesthetized with ketamine (2.5 mg/kg) and xylazine (5 mg/kg). A 6-mm corneal trephine marked the central corneal epithelium bilaterally that was then manually debrided with a no. 64 Beaver blade. Aqueous solutions of chlorhexidine gluconate were formulated to achieve concentrations of 0. 
RESULTS
Toxicity studies. Five rabbits (10 eyes) were studied, including concomitant control eyes, for each chlorhexidine concentration. Figure 1 compares the healing rates for the various concentrations of chlorhexidine. Rabbits receiving aqueous chlorhexidine (0.1, 0.2, 0.4, 0.5, and 1%) were not statistically different from saline controls (P > 0.45, P > 0.5, P > 0.5, P > 0.5, P > 0.5, respectively). The rates of epithelial healing to complete closure were 0.076 mm2/h after receiving 4% aqueous chlorhexidine and 0.546 mm2/h after receiving 2% aqueous chlorhexidine; these rates were significantly different from the control, 0.938 mm2/h (P < 0.01 and P < 0.05, respectively). Bulbar conjunctival hyperemia and lid mattering occurred during the first 60 h after topical application of 4 and 2% aqueous chlorhexidine; application of 1% aqueous chlorhexidine resulted in mild conjunctival hyperemia that resolved within 24 h. No adverse effects were noted by penlight exam for concentrations of <1%.
Antimicrobial activity studies. All organisms tested were inhibited by chlorhexidine in both the disk diffusion (Fig. 2) and broth studies (Table 1) . Growth inhibition was noted for each organism for all concentrations of aqueous chlorhexidine studied, except for moderate growth by Enterobacter aerogenes in the broth diffusion study at a disk concentration of 0.1% chlorhexidine (equivalent to 0.002% in the growth medium). Figures 3 and 4 show the bacterial count of Staphylococcus epidermidis recovered from the rabbit conjunctival sac after treatment with wash solutions of aqueous chlorhexidine. Analyses of the 10-min recovery study (Fig. 3) showed all treatment groups statistically different from one another (P < 0.001). Over the 2-h period (Fig. 4) , the chlorhexidinetreated groups were also significantly different from salinetreated controls at each sampling time (P < 0.001). 
DISCUSSION
Complete ocular antisepsis preceding intraocular surgery is the goal of preoperative preparatory maneuvers but with present methods is not realistically achievable. Topical antibacterial agents are effective in reducing the local microbial population but require multiple applications (7, 19) . Of the antiseptic agents currently available for skin preparation, most are too toxic for direct instillation onto the ocular surface. Commercial preparations of chlorhexidine, such as Hibiclens (4% chlorhexidine gluconate in a detergent solution) and Hibitane (0.5% chlorhexidine gluconate in 70% isopropanol), are toxic to the corneal epithelium (14) . De In vitro sensitivity studies with disk diffusion and broth diffusion assays verified the broad antibacterial spectrum (12) of chlorhexidine at all concentrations from 0.1 to 4%. The antimicrobial properties of aqueous chlorhexidine were also studied on the conjunctival surface. These microbial recovery studies, in which an ocular isolate of Staphylococcous epidermidis was used, showed that chlorhexidine significantly reduced the bacterial counts after a single application. Concentrations as low as 0.1% produced a nearly 100-fold decrease over saline-treated eyes after 10 min. Chlorhexidine also showed a persistent effect in suppressing bacterial recovery over a 2-h period after bacterial inoculation.
Aqueous chlorhexidine appears to be an effective topical ocular antiseptic agent that does not affect corneal reepithelialization in concentrations of <1%. With its antimicrobial spectrum against both gram-positive and gram-negative bacteria, chlorhexidine can significantly reduce and persistently suppress the conjunctival microbial population. These studies suggest that a concentration of aqueous chlorhexidine of 0.1 to 0.5% applied topically is relatively safe and effective; however, because the corneal endothelium is sensitive to extremely low levels of this drug (10), the role of topical chlorhexidine as a preoperative antiseptic agent before intraocular surgery remains to be assessed.
